122 related articles for article (PubMed ID: 38341093)
1. Optimal timing of re-planning for head and neck adaptive radiotherapy.
Gan Y; Langendijk JA; Oldehinkel E; Lin Z; Both S; Brouwer CL
Radiother Oncol; 2024 May; 194():110145. PubMed ID: 38341093
[TBL] [Abstract][Full Text] [Related]
2. A novel semi auto-segmentation method for accurate dose and NTCP evaluation in adaptive head and neck radiotherapy.
Gan Y; Langendijk JA; Oldehinkel E; Scandurra D; Sijtsema NM; Lin Z; Both S; Brouwer CL
Radiother Oncol; 2021 Nov; 164():167-174. PubMed ID: 34597740
[TBL] [Abstract][Full Text] [Related]
3. An efficient strategy to select head and neck cancer patients for adaptive radiotherapy.
Gan Y; Langendijk JA; van der Schaaf A; van den Bosch L; Oldehinkel E; Lin Z; Both S; Brouwer CL
Radiother Oncol; 2023 Sep; 186():109763. PubMed ID: 37353058
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo evaluation of tissue heterogeneities corrections in the treatment of head and neck cancer patients using stereotactic radiotherapy.
Pokhrel D; McClinton C; Sood S; Badkul R; Saleh H; Jiang H; Lominska C
J Appl Clin Med Phys; 2016 Mar; 17(2):258-270. PubMed ID: 27074489
[TBL] [Abstract][Full Text] [Related]
6. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.
Huang H; Lu H; Feng G; Jiang H; Chen J; Cheng J; Pang Q; Lu Z; Gu J; Peng L; Deng S; Mo Y; Wu D; Wei Y
Radiat Oncol; 2015 Sep; 10():192. PubMed ID: 26377685
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effectiveness of novel single-intervention adaptive radiotherapy strategies based on daily dose accumulation.
Ciarmatori A; Maffei N; Mistretta GM; Ceroni P; Bernabei A; Meduri B; D'Angelo E; Bruni A; Giacobazzi P; Lohr F; Guidi G
Med Dosim; 2019 Winter; 44(4):379-384. PubMed ID: 30871864
[TBL] [Abstract][Full Text] [Related]
8. Study of volumetric and dosimetric changes during fractionated radiotherapy in head and neck cancers: A single centre experience.
Kumar V; Nautiyal V; Kant R; Gupta M; Bansal S; Ahmad M
J Cancer Res Ther; 2021; 17(1):235-241. PubMed ID: 33723161
[TBL] [Abstract][Full Text] [Related]
9. Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
Leitzen C; Wilhelm-Buchstab T; Stumpf S; Heimann M; Koch D; Schmeel C; Simon B; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H; Müdder T
Strahlenther Onkol; 2019 Jul; 195(7):668-676. PubMed ID: 30915490
[TBL] [Abstract][Full Text] [Related]
10. Optimal virtual monoenergetic image in "TwinBeam" dual-energy CT for organs-at-risk delineation based on contrast-noise-ratio in head-and-neck radiotherapy.
Wang T; Ghavidel BB; Beitler JJ; Tang X; Lei Y; Curran WJ; Liu T; Yang X
J Appl Clin Med Phys; 2019 Feb; 20(2):121-128. PubMed ID: 30693665
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric effects of repeat computed tomography scan during radiotherapy planning in esophagus carcinoma.
Khan A; Singh SN; Ali T; Palod S; Ojha R; Mahendran C; Bhandari V
J Cancer Res Ther; 2022 Dec; 18(Supplement):S293-S298. PubMed ID: 36510979
[TBL] [Abstract][Full Text] [Related]
12. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
[TBL] [Abstract][Full Text] [Related]
13. Automatic segmentation for adaptive planning in nasopharyngeal carcinoma IMRT: Time, geometrical, and dosimetric analysis.
Fung NTC; Hung WM; Sze CK; Lee MCH; Ng WT
Med Dosim; 2020 Spring; 45(1):60-65. PubMed ID: 31345672
[TBL] [Abstract][Full Text] [Related]
14. A novel surrogate to identify anatomical changes during radiotherapy of head and neck cancer patients.
Gros SA; Xu W; Roeske JC; Choi M; Emami B; Surucu M
Med Phys; 2017 Mar; 44(3):924-934. PubMed ID: 28019647
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison between jaw tracking and static jaw techniques in intensity-modulated radiotherapy.
Feng Z; Wu H; Zhang Y; Zhang Y; Cheng J; Su X
Radiat Oncol; 2015 Jan; 10():28. PubMed ID: 25623899
[TBL] [Abstract][Full Text] [Related]
16. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
[TBL] [Abstract][Full Text] [Related]
17. Clinical and dosimetric impact of adaptive intensity-modulated radiotherapy in locally advanced head-and-neck cancer.
Maheshwari G; Dhanawat A; Kumar HS; Sharma N; Jakhar SL
J Cancer Res Ther; 2020; 16(3):600-604. PubMed ID: 32719274
[TBL] [Abstract][Full Text] [Related]
18. Geometric and dosimetric evaluations of atlas-based segmentation methods of MR images in the head and neck region.
Kieselmann JP; Kamerling CP; Burgos N; Menten MJ; Fuller CD; Nill S; Cardoso MJ; Oelfke U
Phys Med Biol; 2018 Jul; 63(14):145007. PubMed ID: 29882749
[TBL] [Abstract][Full Text] [Related]
19. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.
Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P
Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891
[TBL] [Abstract][Full Text] [Related]
20. Multiple-CT optimization: An adaptive optimization method to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers.
Yang Z; Zhang X; Wang X; Zhu XR; Gunn B; Frank SJ; Chang Y; Li Q; Yang K; Wu G; Liao L; Li Y; Chen M; Li H
Radiother Oncol; 2020 Jan; 142():124-132. PubMed ID: 31564553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
